Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease
- 2 April 2010
- journal article
- Published by Elsevier BV in Cell
- Vol. 141 (1), 178-190
- https://doi.org/10.1016/j.cell.2010.02.039
Abstract
No abstract availableThis publication has 66 references indexed in Scilit:
- VEGFR1 Activity Modulates Myeloid Cell Infiltration in Growing Lung Metastases but Is Not Required for Spontaneous Metastasis FormationPLOS ONE, 2009
- Experimental mouse models for hepatocellular carcinoma researchInternational Journal of Experimental Pathology, 2009
- FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?Nature Reviews Cancer, 2008
- Elevated levels of placental growth factor represent an adaptive host response in sepsisThe Journal of Experimental Medicine, 2008
- Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodiesProceedings of the National Academy of Sciences of the United States of America, 2007
- Increased Melanoma Growth and Metastasis Spreading in Mice Overexpressing Placenta Growth FactorThe American Journal of Pathology, 2006
- Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesisProceedings of the National Academy of Sciences of the United States of America, 2006
- Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repairJCI Insight, 2006
- Placenta growth factor is over-expressed and has prognostic value in human breast cancerEuropean Journal of Cancer, 2005
- The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancerCancer Letters, 2004